Data / Form D filings / Cytosolix, Inc.
Cytosolix, Inc.: Form D filing
Cytosolix, Inc., a biotechnology company in Tolland, CT, filed a Form D with the SEC in 2023. The latest, on June 28, 2023, reports $6.6 million sold of a $6.6 million offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 97 ROBBIE ROAD, Tolland, CT, 06084
- Phone
- (203) 606-5077
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1980943
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 28, 2023 | New notice | $6,605,171 | $6,605,171 | 12 | Jun 12, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jason J. Whitmire | Director | |
| John J. Deacon | Executive Officer, Director | |
| Colin J. Foster | Executive Officer, Director | |
| Alex J. Brunicki | Director |
Other biotechnology companies in Connecticut that filed recently
- Allyx Therapeutics, Inc. $27.9 million · Oct 21, 2026
- Cloverleaf Bio, Inc. $14.8 million · Sep 9, 2026
Every Form D from the week of Jun 26, 2023 · All recent filings in Connecticut · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Cytosolix, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.